SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016143
Filing Date
2022-08-09
Accepted
2022-08-09 16:54:29
Documents
83
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20220630.htm   iXBRL 10-Q 2805106
2 EX-10.1 axsm-ex10_1.htm EX-10.1 180355
3 EX-10.2 axsm-ex10_2.htm EX-10.2 270082
4 EX-31.1 axsm-ex31_1.htm EX-31.1 18507
5 EX-31.2 axsm-ex31_2.htm EX-31.2 18325
6 EX-32.1 axsm-ex32_1.htm EX-32.1 8456
7 EX-32.2 axsm-ex32_2.htm EX-32.2 8461
  Complete submission text file 0000950170-22-016143.txt   10666710

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT axsm-20220630_def.xml EX-101.DEF 228991
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20220630_pre.xml EX-101.PRE 421572
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20220630.xsd EX-101.SCH 70560
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT axsm-20220630_cal.xml EX-101.CAL 55260
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20220630_lab.xml EX-101.LAB 560702
77 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20220630_htm.xml XML 1765728
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 221149175
SIC: 2834 Pharmaceutical Preparations